𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined quantitative and mechanistic study of drug–membrane interactions using a novel 2H NMR approach

✍ Scribed by David A. Middleton; David G. Reid; Anthony Watts


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
109 KB
Volume
93
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


Several analytical methods are available for determining the partition coefficients of drug compounds in model phospholipid membranes, but such methods provide little information at the molecular level about how the membrane affinity of drugs relates to their interactions with the lipid molecules. A new 2 H nuclear magnetic resonance (NMR) approach has been developed here that quantifies the affinity of 2 Hlabeled small molecules for different phospholipid membranes and, simultaneously, provides information on the mechanism of the drug-membrane interaction. In the example given, 2 H NMR analysis of a weakly basic ion pump inhibitor found that the drug partitioned preferentially into membranes of predominantly unsaturated or short-chain phospholipids. The 2 H NMR analysis also suggested that the membrane specificity of the drug was directly correlated to the ability of its phenyl moiety to penetrate into the interior of the lipid bilayer. The 2 H NMR approach could be of value in guiding medicinal chemistry toward or away from structures promoting interactions with specific types of biological membranes.


📜 SIMILAR VOLUMES


Conformation of the tridimensional struc
✍ Giangiacomo Beretta; Roberto Artali; Enrico Caneva; Roberto Maffei Facino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

## Abstract 1,2,3,4,6‐Penta‐__O__‐galloyl‐β‐D‐glucopyranose (PGG) is a polyphenolic compound found in substantial amounts in a number of medicinal herbs. We report (i) its conformational analysis by solution NMR and molecular dynamics calculation and (ii) theoretical study of its interaction with a

A novel method for the synthesis of carb
✍ William J. Wheeler; Sylvia H. Chay; Jennifer L. Herman; Douglas D. O'Bannon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 1 views

## Abstract Sumitriptan (1), a non‐selective 5‐HT~1B/1D~ agonist is an effective therapeutic agent for the acute treatment of migraine, but it is contraindicated for use in patients with known heart disease. The first Selective Serotonin One F Receptor Agonist (SSOFRA), 5‐(4′‐fluorobenz‐amido)‐3‐(_